Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (SHE:300357)
China flag China · Delayed Price · Currency is CNY
25.30
-0.10 (-0.39%)
May 6, 2026, 3:04 PM CST

SHE:300357 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash & Equivalents
847.05797.221,1191,171840.69649.99
Short-Term Investments
-74.58----
Trading Asset Securities
478560.23196.09117.39295.05370.93
Cash & Short-Term Investments
1,3251,4321,3151,2891,1361,021
Cash Growth
3.02%8.91%2.03%13.47%11.25%14.62%
Accounts Receivable
295.26242.93251.04202.92254.31238.12
Other Receivables
6.92---19.8111.13
Receivables
302.18242.93251.04202.92274.12249.26
Inventory
53.6854.7657.7359.0448.4153.75
Other Current Assets
83.5131.5327.7819.1718.8617.58
Total Current Assets
1,7641,7611,6511,5701,4771,342
Property, Plant & Equipment
752.08842.85780.09704.84444.61301.62
Long-Term Investments
252.86108.3277.9474.2178.483.35
Other Intangible Assets
126.59149.46162.79161.38139.6794
Long-Term Deferred Tax Assets
6.25.585.65.034.875.81
Long-Term Deferred Charges
29.5426.3125.2734.3853.286.05
Other Long-Term Assets
4.583.645.9412.42-19.63
Total Assets
2,9362,8972,7092,5622,1981,932
Accounts Payable
14.4231.4147.777.997.685.08
Accrued Expenses
20.2737.2735.1333.5729.8935.54
Short-Term Debt
5512.6334.39--
Current Portion of Leases
4.184.085.036.83.985.86
Current Income Taxes Payable
16.331.9810.569.2626.0850.32
Current Unearned Revenue
0.640.530.510.380.420.42
Other Current Liabilities
6.6764.370.9584.6434.7110.78
Total Current Liabilities
67.51144.57182.58177.04102.75108
Long-Term Leases
10.249.327.9321.2612.281.95
Long-Term Unearned Revenue
31.2731.7433.5330.9327.4324.91
Long-Term Deferred Tax Liabilities
0.020.030.170.20.080.5
Other Long-Term Liabilities
--26.0829.0328.22-
Total Liabilities
109.04185.67250.3258.46170.76135.36
Common Stock
523.58523.58523.58523.58523.58523.58
Additional Paid-In Capital
128.19128.19128.19128.19128.19128.19
Retained Earnings
2,0871,9681,7021,5331,3281,084
Comprehensive Income & Other
0.020.030.040.030.030
Total Common Equity
2,7392,6192,3542,1851,9801,736
Minority Interest
88.5592.27105.12118.6147.4960.54
Shareholders' Equity
2,8272,7122,4592,3042,0271,797
Total Liabilities & Equity
2,9362,8972,7092,5622,1981,932
Total Debt
19.4318.4125.5962.4416.267.81
Net Cash (Debt)
1,3061,4141,2891,2261,1191,013
Net Cash Growth
2.34%9.64%5.14%9.54%10.50%13.74%
Net Cash Per Share
2.492.702.462.342.141.93
Filing Date Shares Outstanding
523.58523.58523.58523.58523.58523.58
Total Common Shares Outstanding
523.58523.58523.58523.58523.58523.58
Working Capital
1,6971,6171,4691,3931,3741,234
Book Value Per Share
5.235.004.504.173.783.32
Tangible Book Value
2,6122,4702,1912,0241,8401,642
Tangible Book Value Per Share
4.994.724.183.873.513.14
Buildings
-638.01428.52423.31175.67137.89
Machinery
-168.95135.42115.9995.5177.11
Construction In Progress
-175.46323.16227.86226.24140.33
Source: S&P Global Market Intelligence. Standard template. Financial Sources.